切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2021, Vol. 15 ›› Issue (05) : 324 -326. doi: 10.3877/cma.j.issn.1674-0807.2021.05.011

病例报告

原发性乳腺淋巴瘤一例及文献复习
易顺1, 谭米多1, 周围1,()   
  1. 1. 412007 湖南 株洲,中南大学湘雅医学院附属株洲医院乳腺外科
  • 收稿日期:2019-10-06 出版日期:2021-10-01
  • 通信作者: 周围

Primary breast lymphoma: one case report and literature review

Shun Yi1, Miduo Tan1, Wei Zhou1()   

  • Received:2019-10-06 Published:2021-10-01
  • Corresponding author: Wei Zhou
引用本文:

易顺, 谭米多, 周围. 原发性乳腺淋巴瘤一例及文献复习[J]. 中华乳腺病杂志(电子版), 2021, 15(05): 324-326.

Shun Yi, Miduo Tan, Wei Zhou. Primary breast lymphoma: one case report and literature review[J]. Chinese Journal of Breast Disease(Electronic Edition), 2021, 15(05): 324-326.

图1 原发性乳腺淋巴瘤彩色超声图 a图所示肿块声像图;b图所示分隔上血流信号(见红圈处);c图所示分隔上测及高阻力动脉频谱
图2 原发性乳腺淋巴瘤X线摄影图  a、b图分别所示头尾位和内外斜位X线摄影图
图3 原发性乳腺淋巴瘤病理表现(HE ×100)  a、b图分别所示乳腺不同区域的原发性淋巴瘤
[1]
Ryan G, Martinelli G, Kuper-Hommel M, et al. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the international extranodal lymphoma study group [J]. Ann Oncol, 2008, 19(2): 233-241.
[2]
Thomas A, Link BK, Altekruse S, et al. Primary breast lymphoma in the united states: 1975-2013 [J]. J Natl Cancer Inst, 2017, 109(6): djw294.
[3]
Aviles A, Delgado S, Nambo MJ, et al. Primary breast lymphoma: results of a controlled clinical trial [J]. Oncology, 2005, 69(3): 256-260.
[4]
Zhao YF, Jiao F, Liang HQ, et al. Primary malignant non-hodgkin’s lymphoma of the breast: a case report [J]. Oncol Lett, 2014, 8(6): 2597-2600.
[5]
Aviv A, Tadmor T, Polliack A. Primary diffuse large b-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options [J]. Ann Oncol, 2013, 24(9): 2236-2244.
[6]
Cheah CY, Campbell BA, Seymour JF. Primary breast lymphoma [J]. Cancer Treat Rev, 2014, 40(8): 900-908.
[7]
Hosein PJ, Maragulia JC, Salzberg MP, et al. A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era [J]. Br J Haematol, 2014, 165(3): 358-363.
[8]
Nichter LS, Mueller MA, Burns RG, et al. First report of nodal marginal zone B-cell lymphoma associated with breast implants [J]. Plast Reconstr Surg, 2012, 129(3): 576e-578e.
[9]
Rupani A, Frame JD, Kamel D. Lymphomas associated with breast implants: a review of the literature [J]. Aesthet Surg J, 2015, 35(5): 533-544.
[10]
De Jong D, Vasmel WL, De Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants [J]. JAMA, 2008, 300(17): 2030-2035.
[11]
Miranda RN, Aladily TN, Prince HM, et al. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients [J]. J Clin Oncol, 2014, 32(2): 114-120.
[12]
Avenia N, Sanguinetti A, Cirocchi R, et al. Primary breast lymphomas: a multicentric experience [J]. World J Surg Oncol, 2010, 8:53.
[13]
Jung SP, Kim M, Han KM, et al. Primary breast lymphoma: a single institution’s experience [J]. J Korean Surg Soc, 2013, 84(5): 267-272.
[14]
Inic Z, Inic M, Zegarac M, et al. Three cases of combined therapy in primary breast lymphoma (pbl) with successful outcomes [J]. Clin Med Insights Oncol, 2013, 7:159-163.
[15]
Domchek SM, Hecht JL, Fleming MD, et al. Lymphomas of the breast: primary and secondary involvement [J]. Cancer, 2002, 94(1): 6-13.
[16]
Jabbour G, El-Mabrok G, Al-Thani H, et al. Primary breast lymphoma in a woman: a case report and review of the literature [J]. Am J Case Rep, 2016, 17:97-103.
[17]
Surov A, Holzhausen HJ, Wienke A, et al. Primary and secondary breast lymphoma: prevalence, clinical signs and radiological features [J]. Br J Radiol, 2012, 85(1014): e195-205.
[18]
Wiseman C, Liao KT. Primary lymphoma of the breast [J]. Cancer, 1972, 29(6): 1705-1712.
[19]
Jeanneret-Sozzi W, Taghian A, Epelbaum R, et al. Primary breast lymphoma: patient profile, outcome and prognostic factors. a multicentre rare cancer network study [J]. BMC Cancer, 2008, 8:86.
[20]
Jennings WC, Baker RS, Murray SS, et al. Primary breast lymphoma: the role of mastectomy and the importance of lymph node status [J]. Ann Surg, 2007, 245(5): 784-789.
[21]
Caon J, Wai ES, Hart J, et al. Treatment and outcomes of primary breast lymphoma [J]. Clin Breast Cancer, 2012, 12(6): 412-419.
[22]
Martelli M, Ferreri AJ, Agostinelli C, et al. Diffuse large B-cell lymphoma [J]. Crit Rev Oncol Hematol, 2013, 87(2): 146-171.
[23]
Yhim HY, Kang HJ, Choi YH, et al. Clinical outcomes and prognostic factors in patients with breast diffuse large b cell lymphoma; consortium for improving survival of lymphoma (CISL) study [J]. BMC Cancer, 2010, 10:321.
[24]
Wadhwa A, Senebouttarath K. Primary lymphoma of the breast: a case series [J]. Radiol Case Rep, 2018, 13(4): 815-821.
[25]
Coiffier B, Lepage E, Briere J, et al. Chop chemotherapy plus rituximab compared with chop alone in elderly patients with diffuse large-B-cell lymphoma [J]. New Engl J Med, 2002, 346(4): 235-242.
[26]
Shao YB, Sun XF, He YN, et al. Clinicopathological features of thirty patients with primary breast lymphoma and review of the literature [J]. Med Oncol, 2015, 32(2): 448.
[27]
Millis RR, Bobrow LG, Rubens RD, et al. Histiocytic lymphoma of breast responds to tamoxifen [j]. Br J Cancer, 1988, 58(6): 808-809.
[28]
Scariano JK, Emery-Cohen AJ, Pickett GG, et al. Estrogen receptors alpha (esr1) and beta (esr2) are expressed in circulating human lymphocytes [J]. J Recept Signal Transduct Res, 2008, 28(3): 285-293.
[29]
Shim GJ, Gherman D, Kim HJ, et al. Differential expression of oestrogen receptors in human secondary lymphoid tissues [J]. J Pathol, 2006, 208(3): 408-414.
[1] 郏亚平, 曾书娥. 含鳞状细胞癌成分的乳腺化生性癌的超声与病理特征分析[J]. 中华医学超声杂志(电子版), 2023, 20(08): 844-848.
[2] 邵华, 那子悦, 荆慧, 李博, 王秋程, 程文. 术前经皮超声造影对乳腺癌腋窝前哨淋巴结转移及负荷的诊断价值[J]. 中华医学超声杂志(电子版), 2023, 20(08): 849-853.
[3] 张旭, 徐建平, 苏冬明, 王彩芬, 王大力, 张文智. 男性乳腺肿块的超声造影特征[J]. 中华医学超声杂志(电子版), 2023, 20(08): 854-859.
[4] 武壮壮, 张晓娟, 史泽洪, 史瑶, 原韶玲. 超声联合乳腺X线摄影及PR、Her-2预测高级别与中低级别乳腺导管原位癌的价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 631-635.
[5] 唐玮, 何融泉, 黄素宁. 深度学习在乳腺癌影像诊疗和预后预测中的应用[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 323-328.
[6] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[7] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[8] 施杰, 李云涛, 高海燕. 腋窝淋巴结阳性Luminal A型乳腺癌患者新辅助与辅助化疗的预后及影响因素分析[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 353-361.
[9] 冯冰, 邹秋果, 梁振波, 卢艳明, 曾奕, 吴淑苗. 老年非特殊型浸润性乳腺癌超声征象与分子生物学指标的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 48-51.
[10] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[11] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[12] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[13] 李智铭, 郭晨明, 庄晓晨, 候雪琴, 高军喜. 早期乳腺癌超声造影定性及定量指标的对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 639-643.
[14] 刘飞, 王影新, 马骍, 辛灵, 程元甲, 刘倩, 王悦, 张军军. 不同介质腔内心电图定位技术在乳腺癌上臂输液港植入术中应用的随机对照研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 760-764.
[15] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
阅读次数
全文


摘要